![Christopher Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Sullivan
Directeur Financier/CFO chez
AVALO THERAPEUTICS, INC.
Fortune : 753 485 $ au 30/06/2026
Profil
Christopher Sullivan is currently Chief Financial Officer at Avalo Therapeutics, Inc. since 2022.
Formerly, Mr. Sullivan was Controller at Sucampo Pharmaceuticals LLC from 2017 to 2018, Controller at CapForce, Inc. from 2015 to 2017, and Senior Manager at Ernst & Young LLP.
Mr. Sullivan completed undergraduate studies at the University of Maryland.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AVALO THERAPEUTICS INC 0,08 % | 10/06/2026 | 40 773 ( 0,08 % ) | 753 485 $ | 30/06/2026 |
Postes actifs de Christopher Sullivan
| Sociétés | Poste | Début |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Directeur Financier/CFO | 14/02/2022 |
Anciens postes connus de Christopher Sullivan
| Sociétés | Poste | Fin |
|---|---|---|
| SUCAMPO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2018 |
| CAPFORCE INC. | Comptroller/Controller/Auditor | 01/08/2017 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
Formation de Christopher Sullivan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
OpGen, Inc.
 OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
